Health economic impact of COPD

The financial cost of COPD continues to rise1

Costs associated with COPD are estimated to be $50 billion by 2020, including direct and indirect costs.


Costs for COPD are largely incurred through hospitalizations1


Patients may live with COPD and its associated comorbidities for many years.2

Average life expectancy of a patient with COPD is beyond 65 years of age2


Comorbidities are common among COPD patients, and they have a significant impact on health care costs3,4


 


 

References:

  1. Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31-45.
  2. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis. 2009;4:137-148.
  3. Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012;12:26.
  4. Singh JA, Yu S. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the US National Emergency Department Sample (NEDS). Respir Res. 2016;17:1.